A Study to Evaluate an Intra-Articular Injection of ZILRETTA Versus Triamcinolone Acetonide, Immediate Release in Subjects With Osteoarthritis of the Hip
May 07, 2025
―
Enekinragene Inzadenovec (Pcrx-201)
Osteoarthritis (Oa) Of The Knee
Phase II
Recruiting
A Study to Assess Safety and Tolerability of PCRX-201 in Subjects With Painful Osteoarthritis of the Knee
Mar 13, 2025
―
Iovera° System, Sham Iovera° System Treatment
Spasticity, Cerebral Or Spinal Condition
Phase III
Recruiting
Study to Assess the Efficacy and Safety of Iovera®° System in Subjects With Upper Extremity Spasticity
Mar 25, 2024
―
Zilretta, Tca-Ir
Glenohumeral Osteoarthritis
Phase III
Recruiting
ZILRETTA in Subjects With Shoulder Osteoarthritis
Feb 13, 2024
―
Bupivacaine, Exparel
Postoperative Pain
Phase I
Recruiting
Study to Evaluate the Pharmacokinetics and Safety of EXPAREL for Postoperative Analgesia in Subjects Undergoing Cardiac Surgery
Jan 18, 2024
―
Liposomal Bupivacaine 13.3, Bupivacaine
Healthy
Phase I
Completed
Phase 1, Dose Escalation Study to Evaluate of Safety, Pharmacokinetics and Pharmacodynamics of Liposomal Bupivacaine 13.3 Administered Via a Single Intrathecal Injection to Healthy Volunteers
Phase 3, Sciatic Nerve Block With EXPAREL for Subjects Undergoing Bunionectomy
Nov 15, 2021
―
Fx201
Osteoarthritis, Knee
Phase I
Active Not Recruiting
Study to Evaluate the Safety and Tolerability of FX201 in Patients with Osteoarthritis of the Knee
Oct 03, 2019
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Pacira Pharmaceuticals (PCRX) have in its pipeline
PCRX is currently developing the following drugs: Zilretta, Triamcinolone Acetonide, Enekinragene Inzadenovec (Pcrx-201), Iovera° System, Sham Iovera° System Treatment. These drug candidates are in various stages of clinical development as the company works toward FDA approval.